These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2453418)

  • 21. [Hematopoietic stem-cell transplantation in aplastic anemia].
    Hernández-Rivera EG
    Rev Invest Clin; 2005; 57(2):298-304. PubMed ID: 16524071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transfusion requirements after HLA-identical marrow transplantation in 82 patients with aplastic anemia.
    Wulff JC; Santner TJ; Storb R; Banaji M; Buckner CD; Clift R; Stewart P; Sanders J; Slichter S; Thomas ED
    Vox Sang; 1983; 44(6):366-74. PubMed ID: 6349124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone marrow transplantation in Thailand.
    Issaragrisil S; Visuthisakchai S; Suvatte V; Chandanayingyong D; Piankijagum A
    Transplant Proc; 1994 Aug; 26(4):2348-9. PubMed ID: 8066770
    [No Abstract]   [Full Text] [Related]  

  • 24. Successful allogeneic hematopoietic stem cell transplantation using triple agent immunosuppression in severe aplastic anemia patients.
    Kim HJ; Park CY; Park YH; Kim YJ; Kim DW; Min WS; Kim CC
    Bone Marrow Transplant; 2003 Jan; 31(2):79-86. PubMed ID: 12621487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunosuppressive therapy versus bone marrow transplantation for children with aplastic anemia.
    Werner EJ; Stout RD; Valdez LP; Harris RE
    Pediatrics; 1989 Jan; 83(1):61-5. PubMed ID: 2642621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prolonged remission of severe aplastic anemia after ALG pretreatment and HL-A-semi-incompatible bone-marrow cell transfusion.
    Jeannet M; Rubinstein A; Pelet B; Kummer H
    Transplant Proc; 1974 Dec; 6(4):359-63. PubMed ID: 4280163
    [No Abstract]   [Full Text] [Related]  

  • 27. A permissive effect of cyclosporin on the development of isohaemagglutinins of graft origin in ABO-mismatched organ transplantation.
    Watzke H; Kovarik J; Gassner H
    Nephrol Dial Transplant; 1988; 3(1):89-90. PubMed ID: 3132648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute hemolysis of transfused A2 red cells by an auto-HI antibody.
    Darabi K; Makar RS
    Transfusion; 2008 May; 48(5):964-8. PubMed ID: 18454737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of aplastic anemia: results with bone marrow transplantation, antithymocyte globulin, and a monoclonal anti-T cell antibody.
    Champlin R; Ho W; Bayever E; Winston DJ; Lenarsky C; Feig SA; Gale RP
    Prog Clin Biol Res; 1984; 148():227-38. PubMed ID: 6379661
    [No Abstract]   [Full Text] [Related]  

  • 30. Current status of bone marrow transplantation for severe aplastic anemia: a preliminary report from the International Bone Marrow Transplant Registry.
    Gluckman E
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2597-9. PubMed ID: 3547940
    [No Abstract]   [Full Text] [Related]  

  • 31. Bone marrow transplantation for severe aplastic anaemia.
    Darlow BA; Abbott GD; Beard ME; Fox HW; Hamer JW; Heaton DC
    N Z Med J; 1980 Feb; 91(653):86-9. PubMed ID: 6991993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone marrow transplantation experience for children with aplastic anemia.
    Sanders JE; Whitehead J; Storb R; Buckner CD; Clift RA; Mickelson E; Appelbaum FR; Bensinger WI; Stewart PS; Doney K
    Pediatrics; 1986 Feb; 77(2):179-86. PubMed ID: 3511444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Erythrocyte repopulation after major ABO incompatible transplantation with lymphocyte-depleted bone marrow.
    Bär BM; Van Dijk BA; Schattenberg A; de Man AJ; Kunst VA; de Witte T
    Bone Marrow Transplant; 1995 Dec; 16(6):793-9. PubMed ID: 8750272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone marrow transplantation in aplastic anemia and leukemia.
    Hershko C; Gale RP
    Transplant Proc; 1980 Dec; 12(4):612-5. PubMed ID: 7010721
    [No Abstract]   [Full Text] [Related]  

  • 35. [ABO incompatibility in allogeneic bone marrow transplantation].
    Quabeck K; Beelen DW; Mahmoud HK; Schaefer UW; Schmidt CG; Henneberg-Quester KB; Luboldt W
    Beitr Infusionther Klin Ernahr; 1987; 18():310-5. PubMed ID: 3326589
    [No Abstract]   [Full Text] [Related]  

  • 36. Efficacy of a cyclophosphamide-procarbazine-antithymocyte serum regimen for prevention of graft rejection following bone marrow transplantation for transfused patients with aplastic anemia.
    Smith BR; Guinan EC; Parkman R; Ferrara J; Levey RH; Nathan DG; Rappeport JM
    Transplantation; 1985 Jun; 39(6):671-3. PubMed ID: 3890295
    [No Abstract]   [Full Text] [Related]  

  • 37. Use of hemapheresis techniques in the management of major ABO incompatible bone marrow transplantation.
    Bussel A; Reviron J; Schenmetzler C; Devergie A; Gluckman E
    Prog Clin Biol Res; 1990; 337():107-13. PubMed ID: 2352968
    [No Abstract]   [Full Text] [Related]  

  • 38. [Severe aplastic anemia treated by allogeneic bone marrow transplantation, using immunoadsorbent for major ABO incompatibility].
    Toyoda Y; Tonouchi T; Mimaya J; Yamamoto M; Sakata K; Nakao J
    Rinsho Ketsueki; 1985 Jul; 26(7):1135-9. PubMed ID: 3903258
    [No Abstract]   [Full Text] [Related]  

  • 39. [Bone marrow transplantation in pediatric patients: review of progress].
    Inoue S
    Gan To Kagaku Ryoho; 1987 Apr; 14(4):994-1003. PubMed ID: 3551848
    [No Abstract]   [Full Text] [Related]  

  • 40. [Serological determination of human blood chimerism].
    Avdeeva RA; Poreshina LP; Liubimova LS; Khoroshko ND; Zotikov EA
    Lab Delo; 1970; 10():596-9. PubMed ID: 4099561
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.